Blanket Purchase Agreement 36C24121A0025

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a blanket purchase agreement to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, to provide radiopharmaceuticals in support of nuclear medicine services. The BPA establishes a single award vehicle valued at up to $6.6M over its period of performance from February 2021 through January 2026. Against this agreement, the agency has issued multiple firm fixed price call orders for radiopharmaceutical delivery from Jubilant Radiopharma's location in Boston, Massachusetts. These include a call valued at approximately $655K for the period February 2023 through January 2026, another valued at approximately $263K for February 2022 through January 2023, and one valued at approximately $489K for February 2021 through January 2022. No set-aside provisions were applied to these awards made under the BPA.

The originating pre-solicitation notice sought radiopharmaceuticals and test supplies to support the nuclear medicine programs across the facilities of VISN 1, which serves veterans in the Boston region. As the sole awardee under the BPA, Jubilant Radiopharma will provide these specialized pharmaceutical products to meet the diagnostic imaging and treatment needs of veterans within the network, delivering critical supplies for nuclear medicine procedures on an as-needed basis through the end date of the BPA's period of performance.